Key Insights

Highlights

Success Rate

80% trial completion

Treatment Research

9 treatments under study, led by Endoluminal Treament Of Thoracic Lesions

Research Leaders

7 sponsors active, led by Medtronic Cardiovascular

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 47/100

Termination Rate

14.3%

1 terminated out of 7 trials

Success Rate

80.0%

-6.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

4 of 4 completed with results

Key Signals

4 with results80% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (5)
Phase 2/3 (1)

Trial Status

Completed4
Enrolling By Invitation1
Unknown1
Terminated1

Trial Success Rate

80.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (7)

Research Network

Common Treatments

  • Endoluminal Treament Of Thoracic Lesions1
  • Ecggated Ct1
  • Valiant Mona Lsa Stent Graft System1
  • Talent Thoracic Stent Graft1
  • Open Repair1

Active Sponsors

  • Medtronic Cardiovascular3
  • Medtronic1
  • Massachusetts General Hospital1
  • Bolton Medical1
  • Matthew Eagleton1

Top Investigators

Related Conditions

  • Thoracoabdominal Aortic Aneurysm1
  • Renal Artery Aneurysm1
  • And Penetrating Atherosclerotic Ulcers1
  • Ascending Aorta Aneurysm1
  • Superior Mesenteric Artery Aneurysm1

Activity Timeline